PDF(Pubmed)
Abstract：
Background: Constipation causes substantial morbidity worldwide. Methods: This survey assessed constipation-related factors in Japan using the Japanese version of the Irritable Bowel Syndrome Quality of Life (IBS-QOL-J) instrument. We also examined the relationship among laxative type, Bristol Stool Form Scale (BSFS) scores, and treatment cost. Finally, we examined differences in satisfaction scores according to laxative type, treatment type, treatment cost, and BSFS score. Results: IBS-QOL-J was higher among those taking salt and/or irritation laxatives. Those paying >JPY 5000 (USD 50.00) had the lowest IBS-QOL-J. IBS-QOL-J was significantly lower among those with a BSFS score of 1 or 2 (severe constipation). Conclusions: This study\'s findings suggest that a variety of factors, including treatment type and cost, are associated with defecation satisfaction. Those who had hard stools, used multiple laxatives, or spent more on treatment were less satisfied. Future strategies should target therapies that do not require multiple laxatives with lower treatment costs. Adequate defecation with a small number of appropriate laxatives at minimal cost appears to improve defecation satisfaction. It is desirable to identify appropriate laxatives and improve dietary habits and exercise routines. It is also necessary to stop blindly increasing laxative usage and properly diagnose constipation disorders such as anatomical abnormalities other than functional constipation.
摘要：
背景：便秘在全球范围内引起大量发病率。方法：这项调查使用日本版本的肠易激综合征生活质量（IBS-QOL-J）工具评估了日本的便秘相关因素。我们还检查了泻药类型之间的关系，布里斯托尔凳子表格量表（BSFS）得分，和治疗费用。最后,我们根据泻药类型检查了满意度得分的差异，治疗类型,治疗费用，和BSFS得分。结果：服用盐和/或刺激性泻药的人中IBS-QOL-J较高。那些支付>5000日元（50.00美元）的IBS-QOL-J最低。在BSFS评分为1或2（严重便秘）的人群中，IBS-QOL-J明显较低。结论：这项研究的结果表明，各种因素，包括治疗类型和费用，与排便满意度有关。那些有硬凳子的人，使用多种泻药，或花更多的治疗不太满意。未来的策略应针对不需要多种泻药且治疗成本较低的疗法。以最低的成本使用少量适当的泻药进行适当的排便似乎可以提高排便满意度。需要确定适当的泻药并改善饮食习惯和锻炼程序。还必须停止盲目增加泻药的使用，并正确诊断便秘障碍，例如功能性便秘以外的解剖学异常。
